Last updated: 11/07/2018 08:39:14
Final Study Report for Protocol 115-135: Comparative Clinical Trial of a Combination of Atovaquone and Proguanil versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults and Children in the Philippines
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Final Study Report for Protocol 115-135: Comparative Clinical Trial of a Combination of Atovaquone and Proguanil versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults and Children in the Philippines
Trial description: Final Study Report for Protocol 115-135: Comparative Clinical Trial of a Combination of Atovaquone and Proguanil versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults and Children in the Philippines
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Bustos DG. Canfield CJ. Canete-Miguel E. Hutchinson DB. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. Journal of Infectious Diseases. 179:1587-90, 1999
Medical condition
Malaria
Product
atovaquone/proguanil
Collaborators
Not applicable
Study date(s)
October 1994 to March 1995
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1995-15-03
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website